| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
CK Life Sciences International Holdings, Inc.
|
24.665m | 73.34% | +24.454m | Nov 25 2025 |
| 2 |
Armistice Capital LLC
|
3.280m | 9.75% | -272.037k | Mar 31 2026 |
| 3 |
Vanguard Capital Management, LLC
|
132.154k | 0.39% | +132.154k | Mar 31 2026 |
| 4 |
Geode Capital Management, L.L.C.
|
79.434k | 0.24% | +62.655k | Mar 31 2026 |
| 5 |
Orca Capital GmbH
|
69.821k | 0.21% | +69.821k | Mar 14 2025 |
|
1
CK Life Sciences International Holdings, Inc.
|
73.34%
24.665m
|
|
2
Armistice Capital LLC
|
9.75%
3.280m
|
|
3
Vanguard Capital Management, LLC
|
0.39%
132.154k
|
|
4
Geode Capital Management, L.L.C.
|
0.24%
79.434k
|
|
5
Orca Capital GmbH
|
0.21%
69.821k
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 83.93% of Virios Therapeutics Inc, with CK Life Sciences International Holdings, Inc. the biggest at 73.34%, followed by Armistice Capital LLC (9.75%) and Vanguard Capital Management, LLC (0.39%). |
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. | |
| The short interest in Virios Therapeutics Inc has fallen over the past 12 months from around 2.2% to 0.7% of the float. Fewer and fewer market participants are betting on falling prices. That points to easing skepticism, as short sellers increasingly unwind their positions. |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


